This is a condition where your blood doesn't carry enough oxygen properly. It happens when an abnormal substance called methemoglobin builds up in your blood. This substance makes the blood look bluish instead of pink. It can be caused by certain medicines, foods, or inherited conditions.
Every report comes from a Lived member, sent anonymously.
Have you tried Methylene Blue for Methemoglobinemia?
Methemoglobinemia is a blood disorder in which too much of the body's hemoglobin, the protein in red blood cells that carries oxygen, is in a form called methemoglobin. Methemoglobin cannot deliver oxygen to the body's tissues properly. Normally the body keeps it below about 1% of hemoglobin, but when the level rises, the tissues receive less oxygen even though the lungs are working normally. The most visible sign is a bluish or grayish color of the skin, lips and nail beds, called cyanosis, that does not improve when the person breathes extra oxygen. Mild cases may cause no other symptoms. As the level climbs, people can develop headache, tiredness, dizziness, shortness of breath and a fast heartbeat, and very high levels can cause confusion, irregular heart rhythms, seizures, coma and death. There are two broad kinds. Acquired methemoglobinemia, the more common kind, is triggered by a medicine, chemical or food and can come on within minutes to hours. Inherited (congenital) methemoglobinemia is present from birth and usually causes a lifelong blue tint rather than a sudden illness.
Acquired methemoglobinemia happens when a substance pushes hemoglobin into the methemoglobin form faster than the body can reverse it. The causes reported most often are numbing medicines and dapsone. Benzocaine, the numbing ingredient in many toothache, mouth and sore throat gels and sprays, is a well-known example; its labels warn that it can cause methemoglobinemia even in someone who has used it before. Lidocaine and prilocaine, numbing medicines used in clinics and in some skin creams, can also cause it. Dapsone, an antibacterial medicine, is a common cause in people who take it regularly. Other triggers include nitrites, such as the inhaled "poppers" sold for recreational use, and some other medicines and industrial chemicals. Young babies are especially vulnerable because the enzyme that clears methemoglobin is less active in early life. In infants, nitrates in contaminated well water are a recognized cause. Benzocaine numbing gels and sprays should not be used on babies or young children, including for teething; current labels say not to use them in children under 3. People with G6PD deficiency, a common inherited red blood cell condition, are also more likely to develop methemoglobinemia after an exposure, and it is harder to treat in them. The inherited forms come from gene changes. In the most common type, a child inherits a faulty copy of the same gene from each parent, so the enzyme that converts methemoglobin back to normal hemoglobin does not work well. Parents usually carry the gene without having the condition. In type I, only red blood cells are affected. In the much rarer type II, the enzyme does not work in cells throughout the body, which also causes serious problems with brain development. A separate inherited form, hemoglobin M disease, comes from a change in the hemoglobin protein itself and can be passed on by one parent.
Doctors suspect methemoglobinemia when someone looks blue or gray but the color does not improve with oxygen, especially after a recent exposure to a known trigger. A drawn blood sample can look dark chocolate brown rather than red. A standard fingertip pulse oximeter, the clip that estimates oxygen saturation, is unreliable in this condition. As methemoglobin rises, the reading tends to settle around 85% regardless of how much oxygen the blood is actually carrying. A routine blood gas test can also look misleadingly normal, because it measures oxygen dissolved in the blood rather than how much hemoglobin can carry. The diagnosis is confirmed with co-oximetry, a blood test on a specialized blood gas analyzer that measures the different forms of hemoglobin directly and reports methemoglobin as a percentage. Levels under about 10% usually cause no symptoms; treatment is generally considered above 20% when someone has symptoms, or above 30% even without them. When there is no obvious trigger, or the blue color has been present since birth, further tests look for an inherited cause, including measuring the activity of the enzyme that clears methemoglobin, testing the hemoglobin protein and genetic testing. Testing for G6PD deficiency matters too, because it changes which treatment is safe.
The first step in acquired methemoglobinemia is to find and stop the cause. In mild cases, that and close observation are often enough, since the body gradually converts methemoglobin back to normal hemoglobin on its own. When symptoms are significant or the level is high, the standard treatment is methylene blue, a medicine given through a vein in the hospital that speeds up the body's own recovery pathway. Most people improve after a single dose, and some need a second. Methylene blue temporarily turns the urine and sometimes the skin blue or green. It is not used in people with G6PD deficiency, because it can break down red blood cells in them and often does not work. It can also cause serotonin syndrome, a dangerous reaction, in people taking certain antidepressants (such as SSRIs like sertraline, SNRIs like duloxetine, or MAOIs) or opioid pain medicines, so the care team needs to know about these. With dapsone and similar causes, the level can climb again after it first improves, so monitoring often continues for some time. When methylene blue cannot be used or does not work, options include high-dose vitamin C, which lowers methemoglobin more slowly (over up to a day), exchange transfusion, which replaces the person's blood with donor blood, and in some cases hyperbaric oxygen, which means breathing pure oxygen inside a pressurized chamber. Evidence for these alternatives comes mostly from case reports and small series. Inherited methemoglobinemia is handled differently. People with type I often need no regular treatment; some take vitamin C or riboflavin (vitamin B2) by mouth, mainly to reduce the blue color. There is no treatment for the neurological problems of type II. Hemoglobin M disease usually needs no treatment, and methylene blue does not work for it.
Acquired methemoglobinemia usually resolves completely once the cause is removed and, when needed, treated. Once the level is back to normal, there are usually no lasting effects. Afterward, the most important step is knowing what caused it, recording it as a medicine reaction, and avoiding that trigger in the future, including over-the-counter numbing products. People with type I inherited methemoglobinemia usually live a normal lifespan. Many feel well, though some notice tiredness or breathlessness with exertion, and others may comment on their skin color. Because their red blood cells already have less capacity to clear methemoglobin, they are more sensitive to the same medicines and chemicals that cause acquired cases, and they need to tell every clinician, dentist and anesthesia team about the diagnosis. Type II is far more serious. Children typically develop severe developmental and movement problems in the first months of life and need lifelong specialized care, and life expectancy is greatly shortened. Families who have a child with an inherited form may find genetic counseling useful when planning future pregnancies.
Arrange a routine visit if you or your child has had a bluish tint since birth or there is a family history of methemoglobinemia, so the cause can be properly tested. If skin, lips or nails turn blue, gray or unusually pale after using a numbing gel or spray, taking dapsone, inhaling nitrites or another possible exposure, stop the product and get medical care right away, especially if it comes with a fast heartbeat, headache, dizziness or unusual tiredness. Infants with a sudden blue or gray color need urgent assessment. Call 911 for severe shortness of breath, confusion, a seizure or loss of consciousness in someone who may have methemoglobinemia. Tell the responders about any recent numbing medicine, dapsone or nitrite exposure, since a home or ambulance oxygen reading can be misleading in this condition.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Methemoglobinemia is like, what's helped you, or ask the community a question.